drugset / Trial / NCT00044707

Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide

NCT00044707

Phase 2 Completed 24 enrolled AstraZeneca
RandomizedCrossoverSingle-blindTreatment

Summary

This is a randomized, single-blind, placebo-controlled, crossover study to examine the effect of pramlintide on the pharmacokinetics of an orally administered medication

Timeline

Start
2002-08
Primary completion
2002-09
Completion
2002-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pramlintide Peptide Subcutaneous